Prescription medication · Central Alpha-2 Agonist (Muscle Relaxant)
tizanidine
Also sold as Zanaflex. Tizanidine is used to treat spasticity in adults.
Data updated 2026-05-15
- 22,750
- FDA reportsModerately reported
- 17
- InteractionsSeveral interactions
- 1
- Recall record
What the data shows
tizanidine (Zanaflex) is a prescription Central Alpha-2 Agonist (Muscle Relaxant), reported at a middle-of-the-pack volume (22,750 FDA reports), with 17 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
tizanidine (Zanaflex) is a prescription Central Alpha-2 Agonist (Muscle Relaxant). Tizanidine is used to treat spasticity in adults.
Tizanidine is a muscle relaxant. It is used to treat spasticity, which is when your muscles are tight or stiff.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.08/unit
Generic Available
Yes (14 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Tizanidine is used to treat spasticity in adults.
Common side effects
Dry mouth, Sleepiness, Weakness
Key warnings
Tizanidine can cause low blood pressure, liver problems, and hallucinations.
The sections below are summarized in plain English from tizanidine's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Tizanidine works by affecting certain chemicals in your brain. It is an alpha-2 adrenergic agonist. This action helps to reduce muscle spasms and tightness.
Side Effects (from patient reports)
Based on 22,750 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for tizanidine, by number of reports
- Fatigue
Fatigue
1,693 reports
- Pain
Pain
1,614 reports
- Nausea
Nausea
1,529 reports
- Fall
Fall
1,318 reports
- Headache
Headache
1,289 reports
- Chronic Kidney Disease
Chronic Kidney Disease
1,110 reports
- Diarrhoea
Diarrhoea
1,066 reports
- Dizziness
Dizziness
986 reports
- Arthralgia
Arthralgia
814 reports
- Acute Kidney Injury
Acute Kidney Injury
808 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for tizanidine each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where tizanidine sits
tizanidine has more FDA adverse-event reports than 57% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is tizanidine; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 22,750 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
22,750
Reports Mentioning Death
1,739
7.6% of reports — not proof of cause
Hospitalization Reports
6,474
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | FATIGUE | 1,693 |
| 2 | PAIN | 1,614 |
| 4 | NAUSEA | 1,529 |
| 5 | FALL | 1,318 |
| 6 | HEADACHE | 1,289 |
| 7 | CHRONIC KIDNEY DISEASE | 1,110 |
| 8 | DIARRHOEA | 1,066 |
| 9 | DIZZINESS | 986 |
| 11 | ARTHRALGIA | 814 |
| 12 | ACUTE KIDNEY INJURY | 808 |
| 13 | VOMITING | 792 |
| 14 | ASTHENIA | 778 |
| 15 | ANXIETY | 773 |
| 16 | DYSPNOEA | 756 |
| 17 | GAIT DISTURBANCE | 755 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Tizanidine can cause low blood pressure, liver problems, and hallucinations. It can also make you very sleepy, especially if you drink alcohol or take other medicines that cause sleepiness. Your doctor should check your liver function before you start taking tizanidine and one month after you reach your highest dose. Do not stop taking tizanidine suddenly, as this can cause withdrawal symptoms.
Known Drug Interactions
( 7.2 , 12.3 ) 7.1 Strong CYP1A2 Inhibitors Concomitant use of tizanidine with strong cytochrome P450 1A2 (CYP1A2) inhibitors (e.g., fluvoxamine, ciprofloxacin) is contraindicated.
Mechanism: Ciprofloxacin stops the body from breaking down tizanidine. This can cause tizanidine to build up to dangerous levels in your system.
( 7.2 , 12.3 ) 7.1 Strong CYP1A2 Inhibitors Concomitant use of tizanidine with strong cytochrome P450 1A2 (CYP1A2) inhibitors (e.g., fluvoxamine, ciprofloxacin) is contraindicated.
Mechanism: Fluvoxamine blocks the enzyme that normally clears tizanidine from your body. This leads to much higher amounts of tizanidine in your blood than intended.
( 7.1 ) • Tizanidine (CYP1A2) Substrate: Potential for substantial increases in blood concentrations of tizanidine resulting in hypotension, bradycardia or excessive drowsiness; avoid concomitant use, if possible. 7.2 Tizanidine (CYP1A2 Substrate) Although not studied clinically, famotidine is considered a weak CYP1A2 inhibitor and may lead to substantial increases in blood concentrations of tizanidine, a CYP1A2 substrate. Refer to the full prescribing information for tizanidine.
Mechanism: Famotidine can slow down the body's ability to clear tizanidine, which may lead to dangerously high levels of the drug in your blood.
7.2 Moderate or Weak CYP1A2 Inhibitors Concomitant use of tizanidine with moderate or weak CYP1A2 inhibitors (e.g., zileuton, antiarrhythmics [amiodarone, mexiletine, propafenone, and verapamil], cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine) should be avoided.
Mechanism: Acyclovir blocks a specific liver enzyme that breaks down tizanidine. This causes the muscle relaxant to stay in your body at much higher levels, which can be dangerous.
7.2 Moderate or Weak CYP1A2 Inhibitors Concomitant use of tizanidine with moderate or weak CYP1A2 inhibitors (e.g., zileuton, antiarrhythmics [amiodarone, mexiletine, propafenone, and verapamil], cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine) should be avoided.
Mechanism: Verapamil slows down the liver process that clears tizanidine from your body, which can lead to higher drug levels.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I drink alcohol while taking tizanidine?
What should I do if I feel dizzy after taking tizanidine?
Can I drive while taking tizanidine?
Will tizanidine cure my spasticity?
How long does it take for tizanidine to start working?
Can I take tizanidine with other medicines?
What happens if I take too much tizanidine?
How will I know if tizanidine is working?
Can I switch between the tablet and capsule forms of tizanidine?
What tests will my doctor do while I'm taking tizanidine?
What are the common side effects of tizanidine?
Does tizanidine interact with other medications?
What drug class is tizanidine?
What pregnancy or breastfeeding source fields are listed for tizanidine?
Has tizanidine been recalled?
Active Recalls
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Dr Reddy's Laboratories Limited
Related Medications in Central Alpha-2 Agonist (Muscle Relaxant)
Other drugs grouped near tizanidine - same-class peers and common alternatives.
baclofen
Lioresal, Gablofen
Baclofen is a muscle relaxant.
Compare with tizanidine →
botulinum toxin A
Botox
Botox is a drug that blocks nerve signals to muscles.
Compare with tizanidine →
carisoprodol
Soma
Carisoprodol is a muscle relaxant.
Compare with tizanidine →
chlorzoxazone
Parafon Forte
Chlorzoxazone is a muscle relaxant.
Compare with tizanidine →
cyclobenzaprine
Flexeril, Amrix
Cyclobenzaprine is a muscle relaxant.
Compare with tizanidine →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for tizanidine: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 22,750.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 7.64%.
- misoprostol Δ 0.00 pts · 9,536 reports · Prostaglandin E1 Analog 7.64%death share
- atorvastatin Δ 0.01 pts · 240,204 reports · HMG-CoA Reductase Inhibitor (Statin) 7.65%death share
- risperidone Δ 0.02 pts · 129,958 reports · Atypical Antipsychotic 7.66%death share
- felodipine Δ 0.02 pts · 11,019 reports · Calcium Channel Blocker 7.62%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on tizanidine
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for tizanidine
The FDA label for tizanidine (sold under brand names such as Zanaflex) classifies it as a prescription-only medication in the Central Alpha-2 Agonist (Muscle Relaxant) class. Tizanidine is used to treat spasticity in adults. Official labeling lists 4 commonly reported side effects, including Dry mouth, Sleepiness, Weakness.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 22,750 voluntary reports. The database also lists 17 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.08.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 1 recall record on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: March 11, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages